Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-04-18 Sale |
2023-04-19 4:57 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
6,968 | $28.18 | $196,358 | 43,982 (Direct) |
View |
2023-04-03 Sale |
2023-04-05 8:47 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
5,000 | $25.38 | $126,900 | 584,448 (Direct) |
View |
2023-03-06 Sale |
2023-03-08 9:34 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
5,000 | $16.07 | $80,350 | 589,448 (Direct) |
View |
2022-12-15 Purchase |
2022-12-19 5:02 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director |
2,222 | $18 | $39,996 | 24,942 (Indirect) |
View |
2022-11-23 Purchase |
2022-11-28 4:07 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
5,000 | $16.51 | $82,550 | 1,480,097 (Direct) |
View |
2022-01-04 Sale |
2022-01-06 4:01 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
8,100 | $40 | $324,000 | 594,448 (Direct) |
View |
2021-12-16 Sale |
2021-12-20 4:01 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
3,633 | $40 | $145,328 | 602,548 (Direct) |
View |
2021-12-08 Sale |
2021-12-10 4:01 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
6,367 | $40 | $254,680 | 606,181 (Direct) |
View |
2021-11-01 Sale |
2021-11-03 11:20 am |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $44.41 | $444,100 | 612,548 (Direct) |
View |
2021-10-01 Sale |
2021-10-04 5:01 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $44.36 | $443,600 | 622,548 (Direct) |
View |
2021-09-01 Sale |
2021-09-02 9:06 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $55.86 | $558,600 | 632,548 (Direct) |
View |
2021-08-10 Sale |
2021-08-12 5:11 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director |
800,000 | $54.54 | $43,631,250 | 1,400,000 (Direct) |
View |
2021-08-03 Sale |
2021-08-05 4:32 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $40.07 | $400,700 | 642,548 (Direct) |
View |
2021-04-01 Sale |
2021-04-05 4:30 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $42.95 | $429,500 | 652,548 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 4:30 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
10,000 | $54.23 | $542,300 | 662,548 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-17 Exercise |
2023-04-19 4:57 pm |
N/A 2030-02-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
6,968 | $0 | 43,982 (Direct) |
View |
2023-04-18 Exercise |
2023-04-19 4:57 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
1,031 | $14.12 | 43,982 (Direct) |
View |
2023-04-18 Exercise |
2023-04-19 4:57 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
4,500 | $9.04 | 43,982 (Direct) |
View |
2023-04-18 Exercise |
2023-04-19 4:57 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
1,437 | $4.99 | 43,982 (Direct) |
View |
2022-12-09 Option Award |
2022-12-16 6:28 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
40,000 | $0 | 40,000 (Direct) |
View |
2022-12-08 Option Award |
2022-12-13 4:10 pm |
N/A 2032-12-08 |
Arcturus Therapeutics Holdings Inc. | ARCT | Markels John Director |
26,986 | $0 | 26,986 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 4:08 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 4:07 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 4:06 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
125,000 | $0 | 125,000 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 4:05 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kurata Lance Chief Legal Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2022-08-15 Option Award |
2022-08-17 4:05 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer |
1,068 | $18.42 | 269,303 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 7:16 pm |
N/A 2032-06-23 |
Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 7:16 pm |
N/A 2032-06-23 |
Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 7:16 pm |
N/A 2032-06-23 |
Arcturus Therapeutics Holdings Inc. | ARCT | Marantz Jing L. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 7:15 pm |
N/A 2032-06-23 |
Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-23 Option Award |
2022-06-27 7:15 pm |
N/A 2032-06-23 |
Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:17 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks |
33,000 | $0 | 33,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:17 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO |
85,000 | $0 | 85,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:16 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
150,000 | $0 | 150,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:16 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer |
85,000 | $0 | 85,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:15 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | Kurata Lance Chief Legal Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2021-12-07 Option Award |
2021-12-09 8:13 pm |
N/A 2031-12-06 |
Arcturus Therapeutics Holdings Inc. | ARCT | Marantz Jing L. Director |
26,699 | $0 | 26,699 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:33 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:32 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:31 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:31 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:30 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director |
15,000 | $0 | 15,000 (Direct) |
View |